{
  "pmcid": "7830775",
  "sha256": "aa05a84b4ca204e64a6b79aac2c6cfa0cb2cd8e077ce19d790e8e9f80cbba606",
  "timestamp_utc": "2025-11-10T00:07:25.019773+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.997745098039214,
    "reading_ease": 19.93818627450983,
    "word_count": 255
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Prehospital Plasma in Trauma: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "The unit of randomisation was the individual patient."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included severe traumatic injury with high predicted mortality. The study was conducted in air medical transport settings."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 501 severely injured patients to receive either standard care (crystalloid) or two units of prehospital plasma followed by standard care fluid resuscitation."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial aimed to assess the impact of prehospital plasma on survival in severely injured trauma patients transported by air ambulance."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was 30-day survival."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was not feasible for patients and clinicians, but outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 501 participants were randomised: 251 to the plasma group and 250 to the control group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Analysis was conducted on an intention-to-treat basis."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The model identified 36 unexpected survivors, with a higher proportion in the plasma group (67% vs. 46%, P=0.031). The observed to expected mortality ratio was lower in the plasma group (O/E 0.56 [0.33–0.84] vs. 1.0 [0.73–1.32])."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}